E

Evotec SE

EVO Nasdaq Healthcare · Pharmaceutical Preparations Hamburg, Germany www.evotec.com
$1.58
Mkt Cap 281.4M
We were incorporated on December 8, 1993, as a company with limited liability ( Gesellschaft mit beschr nkter Haftung ) under the laws of Germany under the name EVOTEC BioSystems GmbH, formerly regist…

We were incorporated on December 8, 1993, as a company with limited liability ( Gesellschaft mit beschr nkter Haftung ) under the laws of Germany under the name EVOTEC BioSystems GmbH, formerly registered with the commercial register ( Handelsregister ) of the local court ( Amtsgericht ) of Hamburg, Germany, under the number HRB 54731. On August 7, 1998, we were converted into a German stock corporation ( Aktiengesellschaft ) under the laws of Germany under the name EVOTEC BioSystems Aktiengesellschaft, formerly registered with the commercial register ( Handelsregister ) of the local court ( Amtsgericht ) of Hamburg, Germany, under the number HRB 68223. On February 28, 2002, we changed our name to Evotec OAI AG, and on June 8, 2005, we changed our name to Evotec AG. On March 29, 2019, we converted into a European stock corporation ( Societas Europaea , or SE) under the laws of Germany and the EU called Evotec SE, registered with the commercial register ( Handelsregister ) of the local court ( Amtsgericht ) of Hamburg, Germany, under the number HRB 156381. Since November 10, 1999, we have been listed on the regulated market of the Frankfurt Stock Exchange under the trading symbol EVT and under the ISIN DE0005664809. Our shares are listed under the Segment Prime Standard. On November 3, 2021, our registration statement on Form F-1 (File No.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$862.1M
FCF TTM
-$107.4M
Running full 6-factor analysis…